Oliver Wyman

Telehealth innovation is booming as demand for virtual services skyrockets amidst a pandemic. What will happen next, and what kinds of digital health innovations may be around the corner? In this episode of the Oliver Wyman Health Podcast, Sean Duffy, Co-Founder and CEO of the digital care company Omada Health and a member of the Oliver Wyman Health Innovation Center Leaders Alliance, joins Dan Rubenstein, Co-Founder and CEO of the musculoskeletal care company Physera, and Aditya Lingampally, Principal in Oliver Wyman's Health and Life Sciences practice, to discuss how and why Omada acquired Physera in the midst of a pandemic and how they envision their new collaboration unfolding in time. They also discuss the future of remote care and digital health services, predict the state of the future industry, and share why just providing a physician with Zoom capabilities is merely the beginning of transformations to come. For more information, follow us on Twitter @OWHealthEditor, read our online healthcare publication at health.oliverwyman.com, and see our guest roster: oliverwyman.com/oliverwymanhealthpodcast. Questions or comments? Email Oliver Wyman Health's Editor, jacqueline.dichiara@oliverwyman.com.

Predictions on Telehealth's Looming Innovations

Blog

Health and Life Sciences Practice

The Oliver Wyman Health Podcast features conversations with leaders who are pioneering the transformation of the health market. Oliver Wyman’s Health & Life Sciences Practice is a leader in value-based, consumer-centric healthcare, and serves clients in the pharmaceutical, biotechnology, medical devices, provider, and payer sectors. Topics covered in this series include the business challenges of transforming healthcare from volume to value, consumer engagement, consumer experience, digital health, care delivery models, strategy, leadership, and organization.
Oliver Wyman is a global leader in management consulting that combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. Oliver Wyman is a wholly owned subsidiary of Marsh & McLennan Companies [NYSE: MMC].